Related Experiment Video
Updated: Feb 17, 2026

08:57
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
2.7K
Lung neuroendocrine tumors: pathological characteristics.
Luisella Righi1, Gaia Gatti1, Marco Volante1
1Department of Oncology, San Luigi Hospital, Orbassano, Italy.
Journal of Thoracic Disease
|December 5, 2017
Summary
Lung neuroendocrine tumors (NETs) classification faces challenges due to inconsistent diagnostic reproducibility. Further research is needed to refine criteria for accurate grading and prognosis of these heterogeneous neoplasms.
Area of Science:
- Oncology
- Pathology
Background:
- Lung neuroendocrine tumors (NETs) encompass four histologic types: typical carcinoid (TC), atypical carcinoid (AC), large-cell neuroendocrine carcinoma (LCNEC), and small cell carcinoma (SCC).
- Current classification relies on mitotic counts, necrosis, cytology, histology, and neuroendocrine markers.
Purpose of the Study:
- To highlight persistent challenges in the classification and pathological characterization of lung NETs.
- To address the need for improved diagnostic reproducibility and prognostic criteria.
Main Methods:
- Review of existing classification criteria for lung NETs.
- Analysis of factors contributing to inter-observer variability in diagnosis.
Main Results:
- Despite established criteria, diagnostic reproducibility for lung NETs remains suboptimal.
- Inconsistencies in recognizing necrosis, mitoses, and cytologic details, especially in small samples, contribute to diagnostic challenges.
- Lack of robust prognostic and grading criteria hinders the interpretation of intermediate entities between AC and LCNEC.
Conclusions:
- The current classification system for lung NETs requires refinement to improve diagnostic accuracy and reproducibility.
- Enhanced criteria for grading and prognosis are essential for better patient management and understanding of tumor behavior.